OncoTargets and therapy

Keyphrases

Publications

volume 17, 2024

Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study. OncoTargets and therapy 17 (2024)
Chuangui Chen, Jinsheng Ding, Zhao Ma, Yongjie Xie, Linhua Zhang, Dunwan Zhu
Exosome-Delivered EGFR Induced by Acidic Bile Salts Regulates Macrophage M2 Polarization to Promote Esophageal Adenocarcinoma Cell Proliferation. OncoTargets and therapy 17 (2024)
Yamin Zhang, Wei Wan, Rui Shen, Bohao Zhang, Li Wang, Hongyi Zhang, Xiaoyue Ren, Jie Cui, Jinpeng Liu
Prognostic Factors and Construction of Nomogram Prediction Model of Lung Cancer Patients Using Clinical and Blood Laboratory Parameters. OncoTargets and therapy 17 (2024)
Noboru Yamamoto, Anthony W Tolcher, Navid Hafez, Iwona Lugowska, Rodryg Ramlau, Teresa Macarulla, Junxian Geng, Jian Li, Michael Teufel, Angela Märten, Patricia LoRusso
Efficacy and Safety of the MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series. OncoTargets and therapy 17 (2024)
Xu-Sheng Liu, Chao Liu, Yi-Jia Chen, Dao-Bing Zeng, Ya-Lan Wang, Zhi-Jun Pei
Uterine Burkitt Lymphoma with Rare Extranodal Deposits in the Bone, Breast, and Sacral Canal: A Case Report. OncoTargets and therapy 17 (2024)
Danfei Zhou, Jun Ying, Shanshan Hu, Jiangdong Li, Haijian Liu
A Novel Intergenic Region (chr2: 30,316,870)- ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report. OncoTargets and therapy 17 (2024)
Manabu Hayama, John Charles Riches
Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia. OncoTargets and therapy 17 (2024)
Lan Liu, Meizuo Zhong, Xuan Zhou, Fanhua Kang, Yong Long, Junfeng Li
Treatment of Abdominal Desmoplastic Small Round Cell Tumor Induces Acute Myeloid Leukemia-M5: A Case Report and Literature Review. OncoTargets and therapy 17 (2024)
Janviere Kabagwira, Ryan N Fuller, Paul A Vallejos, Chase S Sugiono, Vola-Masoandro Andrianarijaona, Jazmine Brianna Chism, Michael P O'Leary, David Caba Molina, William Langridge, Maheswari Senthil, Nathan R Wall
Amplifying Curcumin's Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and therapy 17 (2024)
Janviere Kabagwira, Ryan N Fuller, Paul A Vallejos, Chase S Sugiono, Vola-Masoandro Andrianarijaona, Jazmine Brianna Chism, Michael P O'Leary, David Caba Molina, William Langridge, Maheswari Senthil, Nathan R Wall
Amplifying Curcumin's Antitumor Potential: A Heat-Driven Approach for Colorectal Cancer Treatment. OncoTargets and therapy 17 (2024)
Ziwei Wang, Mengyao Li, Ling Bi, Xueqing Hu, Yan Wang
Traditional Chinese Medicine in Regulating Tumor Microenvironment. OncoTargets and therapy 17 (2024)
Chenxi Xie, Xiaopei Hao, Hao Yuan, Chongyu Wang, Razinah Sharif, Haibo Yu
Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. OncoTargets and therapy 17 (2024)
Jie-Ping Yan, Xue Zhang, Lili Yu, Meihua Ye, Yun Chen
Long-Term Follow-Up of Combination Therapy with Sintilimab and Anlotinib in Gallbladder Follicular Dendritic Cell Sarcoma: A Rare Case Report. OncoTargets and therapy 17 (2024)
Yunpeng Feng, Shifeng Qiao, Jie Chen, Xin Wen, Yanlei Chen, Xiaoyu Song, Jiaxin Xu, Xiucheng Qiao, Jing Yang, Shenshen Zhang, Yang Feng, Yu Gao
M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases. OncoTargets and therapy 17 (2024)
Noboru Yamamoto, Anthony W Tolcher, Navid Hafez, Iwona Lugowska, Rodryg Ramlau, Teresa Macarulla, Junxian Geng, Jian Li, Michael Teufel, Angela Märten, Patricia LoRusso
Efficacy and Safety of the MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced Biliary Tract Cancer: A Case Series. OncoTargets and therapy 17 (2024)
Manabu Hayama, John Charles Riches
Taking the Next Step in Double Refractory Disease: Current and Future Treatment Strategies for Chronic Lymphocytic Leukemia. OncoTargets and therapy 17 (2024)
Nana Zhou, Chaoqin Guo, Jingyang Du, Xu Zhang, Qiuran Xu, Xiaoliang Zheng, Linglan Tu
TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer. OncoTargets and therapy 17 (2024)
ZhongHao Jiang, Fan Yang, WanXiang Wang
Applications of Yttrium-90 ( 90 Y) in Hepatocellular Carcinoma. OncoTargets and therapy 17 (2024)
Weixian Liu, Xinxian Huang, Weizhao Luo, Xin-Guang Liu, Weichun Chen
Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin. OncoTargets and therapy 17 (2024)
Ganlu Ouyang, Pei Shu, Yinyin Xue, Feng Luo, Yan Li
Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion. OncoTargets and therapy 17 (2024)
Wenjuan Meng, Qingxia Guo, Gaoyan Tang, Guiyan Han, Guikai Ma, Qingyun Zhang, Rui Li, Shuzhen Liu, Guohua Yu
Thyroid Metastases from Triple-Negative Breast Cancer with High PD-L1 Expression - A Rare Presentation. OncoTargets and therapy 17 (2024)
Ganlu Ouyang, Pei Shu, Yinyin Xue, Feng Luo, Yan Li
Response to Savolitinib in a Patient with Advanced Poorly Differentiated Lung Carcinoma Positive for a Novel EML4-MET Gene Fusion. OncoTargets and therapy 17 (2024)
Wenjuan Meng, Qingxia Guo, Gaoyan Tang, Guiyan Han, Guikai Ma, Qingyun Zhang, Rui Li, Shuzhen Liu, Guohua Yu
Thyroid Metastases from Triple-Negative Breast Cancer with High PD-L1 Expression - A Rare Presentation. OncoTargets and therapy 17 (2024)
Yunfang Wei, Xianlei Zhao, Hong Tang, Jin Ma, Yongfeng Wang, Linxia Li
SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma. OncoTargets and therapy 17 (2024)
Yunfang Wei, Xianlei Zhao, Hong Tang, Jin Ma, Yongfeng Wang, Linxia Li
SIM2: Its Prognostic Significance and Oncogenic Role in Endometrial Carcinoma. OncoTargets and therapy 17 (2024)
Xiang Tan, Zuotao Wu, Mingwu Chen
MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E. OncoTargets and therapy 17 (2024)
Chenxi Xie, Xiaopei Hao, Hao Yuan, Chongyu Wang, Razinah Sharif, Haibo Yu
Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications. OncoTargets and therapy 17 (2024)
Peiyuan Yang, Qiong Wu, Yang Zhou, Yongchao Li
Primary Epithelioid Angiosarcoma of the Jejunal Mesentery Causing Abdominal Bleeding: Case Report and Literature Review. OncoTargets and therapy 17 (2024)
Jie-Ping Yan, Xue Zhang, Lili Yu, Meihua Ye, Yun Chen
Long-Term Follow-Up of Combination Therapy with Sintilimab and Anlotinib in Gallbladder Follicular Dendritic Cell Sarcoma: A Rare Case Report. OncoTargets and therapy 17 (2024)
Peiyuan Yang, Qiong Wu, Yang Zhou, Yongchao Li
Primary Epithelioid Angiosarcoma of the Jejunal Mesentery Causing Abdominal Bleeding: Case Report and Literature Review. OncoTargets and therapy 17 (2024)
Danfei Zhou, Jun Ying, Shanshan Hu, Jiangdong Li, Haijian Liu
A Novel Intergenic Region (chr2: 30,316,870)- ALK Fusion in a Patient with Lung Adenocarcinoma Responding to Crizotinib Combined with Pemetrexed Treatment: A Case Report. OncoTargets and therapy 17 (2024)
Yunpeng Feng, Shifeng Qiao, Jie Chen, Xin Wen, Yanlei Chen, Xiaoyu Song, Jiaxin Xu, Xiucheng Qiao, Jing Yang, Shenshen Zhang, Yang Feng, Yu Gao
M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases. OncoTargets and therapy 17 (2024)
Yixin Hou, Jianguo Yan, Ke Shi, Xiaoli Liu, Fangyuan Gao, Tong Wu, Peipei Meng, Min Zhang, Yuyong Jiang, Xianbo Wang
Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study. OncoTargets and therapy 17 (2024)
Xiang Tan, Zuotao Wu, Mingwu Chen
MAP2K1 K57N Conferred an Acquired Resistance to Furmonertinib, Dabrafenib and Trametinib Combined Therapy in Advanced Lung Adenocarcinoma with EGFR Mutation and BRAF V600E. OncoTargets and therapy 17 (2024)
Jinji Chen, Herong Zhu, Shaohua Chen, Hua Mi
Apolipoprotein E is a Potential Biomarker for Predicting Cancer Prognosis and is Correlated with Immune Infiltration. OncoTargets and therapy 17 (2024)
Jinji Chen, Herong Zhu, Shaohua Chen, Hua Mi
Apolipoprotein E is a Potential Biomarker for Predicting Cancer Prognosis and is Correlated with Immune Infiltration. OncoTargets and therapy 17 (2024)
Nana Zhou, Chaoqin Guo, Jingyang Du, Xu Zhang, Qiuran Xu, Xiaoliang Zheng, Linglan Tu
TSC22D2 Regulates ACOT8 to Delay the Malignant Progression of Colorectal Cancer. OncoTargets and therapy 17 (2024)
Weixian Liu, Xinxian Huang, Weizhao Luo, Xin-Guang Liu, Weichun Chen
Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin. OncoTargets and therapy 17 (2024)
ZhongHao Jiang, Fan Yang, WanXiang Wang
Applications of Yttrium-90 ( 90 Y) in Hepatocellular Carcinoma. OncoTargets and therapy 17 (2024)
Lan Liu, Meizuo Zhong, Xuan Zhou, Fanhua Kang, Yong Long, Junfeng Li
Treatment of Abdominal Desmoplastic Small Round Cell Tumor Induces Acute Myeloid Leukemia-M5: A Case Report and Literature Review. OncoTargets and therapy 17 (2024)
Yamin Zhang, Wei Wan, Rui Shen, Bohao Zhang, Li Wang, Hongyi Zhang, Xiaoyue Ren, Jie Cui, Jinpeng Liu
Prognostic Factors and Construction of Nomogram Prediction Model of Lung Cancer Patients Using Clinical and Blood Laboratory Parameters. OncoTargets and therapy 17 (2024)
Ziwei Wang, Mengyao Li, Ling Bi, Xueqing Hu, Yan Wang
Traditional Chinese Medicine in Regulating Tumor Microenvironment. OncoTargets and therapy 17 (2024)
Jian Xiong, Wenqin Lian, Rui Zhao, Kefei Gao
METTL3/ MALAT1 /ELAVL1 Axis Promotes Tumor Growth in Ovarian Cancer. OncoTargets and therapy 17 (2024)
Jian Xiong, Wenqin Lian, Rui Zhao, Kefei Gao
METTL3/ MALAT1 /ELAVL1 Axis Promotes Tumor Growth in Ovarian Cancer. OncoTargets and therapy 17 (2024)
Zhilin Sha, Qingxiang Gao, Lei Wang, Ni An, Yingjun Wu, Dong Wei, Tong Wang, Chen Liu, Yang Shen
Investigating the Cell Origin and Liver Metastasis Factors of Colorectal Cancer by Single-Cell Transcriptome Analysis. OncoTargets and therapy 17 (2024)
Suqing Liu, Fengling Li, Qinghua Cao, Ning Li, Qian Gao
A Case Study of Gastric Adenocarcinoma and Squamous Cell Carcinoma of the Cervix. OncoTargets and therapy 17 (2024)
Chuangui Chen, Jinsheng Ding, Zhao Ma, Yongjie Xie, Linhua Zhang, Dunwan Zhu
Exosome-Delivered EGFR Induced by Acidic Bile Salts Regulates Macrophage M2 Polarization to Promote Esophageal Adenocarcinoma Cell Proliferation. OncoTargets and therapy 17 (2024)
Xu-Sheng Liu, Chao Liu, Yi-Jia Chen, Dao-Bing Zeng, Ya-Lan Wang, Zhi-Jun Pei
Uterine Burkitt Lymphoma with Rare Extranodal Deposits in the Bone, Breast, and Sacral Canal: A Case Report. OncoTargets and therapy 17 (2024)
Ruoxin Fang, Sha Xu, Jun Gong, Zhengkai Liao
Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report. OncoTargets and therapy 17 (2024)
Ruoxin Fang, Sha Xu, Jun Gong, Zhengkai Liao
Clinical Response of Advanced Lung Adenocarcinoma with Class III BRAF G466V Missense Mutation to Dabrafenib and Trametinib: A Case Report. OncoTargets and therapy 17 (2024)